Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars From Prior Breast Surgery

• Drug: EXC 001
  
  Multiple intradermal injections of EXC 001 and placebo
• Drug: Placebo
  
  Multiple intradermal injections of EXC 001 and placebo

• Experimental: EXC 001
  
  Intervention: Drug: EXC 001
• Placebo Comparator: Placebo
  
  Intervention: Drug: Placebo

Inclusion Criteria:

• Subjects must have previously had breast surgery resulting in unacceptable scars
• Subject has chosen to have the breast scars revised
• Subjects must not be pregnant or lactating

Exclusion Criteria:

• Currently pregnant or pregnant during the 6 months prior to inclusion in the study, or lactating
• Participation in another clinical trial within 30 days prior to the start of the study
• Any other condition or prior therapy, which, in the opinion of the PI, would make the subject unsuitable for this study